Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study

By sjmartinez • September 5, 2023

Hamberg V, Sohrabian A, Volkmann ER, Wildt M, Löfdahl A, Wuttge DM, Hesselstrand R, Dellgren G, Westergren-Thorsson G, Rönnelid J, Andréasson K. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. Arthritis Res Ther. 2023 Sep 4;25(1):162. doi: 10.1186/s13075-023-03141-4. PMID: 37667402; PMCID: PMC10476305.

Tags: autoantibody, Biomarker, interstitial lung disease, Publications, Rheumatology, Ro52, systemic sclerosis

Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance

Markosian C, Buckley CW, Chai-Ho W, Schiller GJ. Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance. Leuk[...]

International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement

Merola JF, Childs BA, Bartley BR, Bissonnette R, Bieber T, Guttman-Yassky E, Paller AS, Simpson EL, Armstrong AW, Irvine AD. International Eczema Council Definitions of[...]

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer

Su Y, Liu C, Lu X, Chuang HY, Li G, Shao S, Kong Y, Lee JW, Ng RH, Wong S, Robert L, Warden C, Liu[...]